Ferumoxtran 10 - Saving Patients' Lives Medical
Latest Information Update: 02 Oct 2021
At a glance
- Originator Saving Patients Lives Medical B.V.
- Class Contrast media; Ferric compounds; Glucans; Oxides
- Mechanism of Action Magnetic resonance imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Prostate cancer
Most Recent Events
- 17 Oct 2019 Phase-III clinical trials in Prostate cancer (Diagnosis) in Netherlands (IV) (EudraCT2018-004310-18)
- 17 Oct 2019 Phase-III clinical trials in Prostate cancer (Diagnosis) in Germany (IV) (EudraCT2018-004310-18)